| Lineni Rosie Makihele, | |
|
1251 Muldoon Rd Ste 116, Anchorage, AK 99504-2098 | |
| (907) 274-8281 | |
| Not Available |
| Full Name | Lineni Rosie Makihele |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 1251 Muldoon Rd Ste 116, Anchorage, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093404022 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lineni Rosie Makihele, 1251 Muldoon Rd Ste 116, Anchorage, AK 99504-2098 Ph: (907) 274-8281 | Lineni Rosie Makihele, 1251 Muldoon Rd Ste 116, Anchorage, AK 99504-2098 Ph: (907) 274-8281 |
News Archive
The Burnham Institute's Jeffrey Smith, Ph.D. has discovered that orlistat, commonly prescribed as an anti-obesity drug, has a positive side-effect: it inhibits cancer growth. Dr. Smith made this discovery using an activity-based proteomics screening technique developed in his laboratory that makes it possible to identify active targets and simultaneously screen for their inhibitors.
A 41-year-old woman from Leicester has spoken of the transformative influence of well-trained doctors as she backed the University of Leicester's Centre for Medicine Appeal, encouraging everyone to play a part in the development of a new generation of healthcare and medical education for the region.
The School of Public Health at Georgia State University has received nearly $400,000 in grant funds to support a three-year effort to reduce rates of diabetes and cardiovascular disease in African-American neighborhoods in southwest Atlanta.
A new study on the preprint server medRxiv* discusses the predictive value of single symptom-based screening to confirm pediatric SARS-CoV-2 cases.
Anadys Pharmaceuticals, Inc. today announced that six of six patients (100%) in the ANA598 200 mg twice daily (bid) arm who were randomized to stop all treatment at Week 24 in an ongoing Phase II trial maintained undetectable levels of virus 12 weeks after stopping treatment, referred to as Sustained Virological Response 12, or SVR12.
› Verified 7 days ago
Mr. Duncan R Brooks, MS, LPC. Counselor Medicare: Not Enrolled in Medicare Practice Location: 1205 E International Airport Rd Ste 100, Anchorage, AK 99518 Phone: 907-570-6382 Fax: 888-972-3679 | |
Carolyn Michaud, OTD OTR/L Counselor Medicare: Not Enrolled in Medicare Practice Location: 4325 Laurel St Ste 102, Anchorage, AK 99508 Phone: 907-569-5660 | |
Patricia Quinn, Counselor Medicare: Not Enrolled in Medicare Practice Location: 741 Sesame St Ste 1b, Anchorage, AK 99503 Phone: 907-406-2642 | |
Mrs. Rebecca Ann Shestakov, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 6952 Cutty Sark St, Anchorage, AK 99502 Phone: 907-982-5562 | |
Parinita Shetty, Counselor Medicare: Not Enrolled in Medicare Practice Location: 7440 Creekside Center Dr, Anchorage, AK 99504 Phone: 907-279-9640 | |
Tau Vaaia, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1709 Bragaw St, Anchorage, AK 99508 Phone: 907-562-5340 | |
Katie Ogin, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2600 Cordova St, Anchorage, AK 99503 Phone: 907-279-9640 |